• Industry news
• Psychiatry

SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders

MENLO PARK, Calif.--November 10, 2009--SRI International, an independent nonprofit research and development organization, announced today that its Center for Neuroscience has entered into a research collaboration with F. Hoffmann-La Roche to study procedures and treatments for cognition impairments in neurological and psychiatric conditions such as Alzheimer's disease, depression and schizophrenia. Research will take place in SRI's laboratories in Menlo Park, California. more

Search the Pharmalicensing Industry news by keyword. Alternatively our advanced search allows you to query by category and therapeutic target.
Category	Therapeutic target
Deals and Alliances Development Financial Results Financings Intellectual Property Regulatory	Cardiovascular Dermatology Endocrine and Metabolic Gastroenterology Genitourinary Hematology Immunology and Allergy Infection Musculoskeletal Neurology Obstetrics and Gynecology Oncology Ophthalmology Psychiatry Pulmonary
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Most Viewed

SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders